Selection from HEOR Bibliography

IMS logo
Search criteria
Condition: Health economics
 
COST OF VISITS ASSOCIATED WITH MANAGEMENT OF INTERNATIONAL NORMALIZED RATIO (INR) RESULTS IN ATRIAL FIBRILLATION (AF) PATIENTS TREATED WITH VITAMIN K ANTAGONIST (VKA)
Authors: Ansolabehere X1, Augier G2
Affiliations: 1QuintilesIMS, Paris La Défense, France, 2Axess Research, Limonest, France
Publications: 22nd international ISPOR, Boston 2017
Document Types: Poster
Countries: France
Abstract: https://ispor.confex.com/ispor/intl2017/research/papers/index.cgi?username=72868&password=462766
Condition Year Language Analysis type
Health economics 2017 English Clinical setting: Primary care, Cost analysis, Survey research
 
 
BIOSIMILARS AND REFERENCE PRICE GROUPS IN GERMANY
Authors: Eheberg D1, Pointner J1, Antoni B1, Gossmann JA1, Batscheider A1
Affiliations: 1IMS Health, Munich, Germany
Publications: 
Document Types: Abstract
Countries: Germany
Condition Year Language Analysis type
Health economics 2016 English Pricing & Reimbursement
 
 
USE OF REAL WORLD DATA IN IDENTIFYING RELEVANT COMPARATORS IN MEDICO ECONOMIC MODELS AT EU5 LEVEL: A CASE STUDY ON MULTIPLE MYELOMA
Authors: Jubert H, Kolahi C, Karusisi N, Mitrofan L
Affiliations: IMS Health France
Publications: 19th ISPOR congress 2016
Document Types: Abstract, Poster
Countries: France, Germany, Italy, Spain, UK
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN150.pdf
Condition Year Language Analysis type
Health economics, Oncology 2016 English Clinical setting: hospital, Population Based Study, Real World Data, Retrospective database analysis
 
 
Estimated budget impact of adopting the affordable care act’s required smoking cessation coverage on united states healthcare payers.
Authors: Baker CL, Ferrufino CP, Bruno M, Kowal S
Affiliations: 
Publications: Advances in Therapy. 2016 November; 25:1-5
Document Types: Manuscript in preparation
Countries: USA
Abstract: http://link.springer.com/article/10.1007/s12325-016-0446-y
Condition Year Language Analysis type
Health economics 2016 English Budget impact, Cost analysis
 
 
A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility
Authors: Gizzo S1, Garcia-Velasco JA2, Heiman F3, Ripellino C3, Bühler K4
Affiliations: 1 Department of Woman and Child Health, University of Padua, Padua, Italy 2 Department of Obstetrics and Gynecology, Rey Juan Carlos University Madrid, Madrid, Spain 3 IMS Health Information Solutions Italy Srl, Milan, Italy 4 Centre for Gynaecology, Endocrinology, and Reproductive Medicine, Ulm and Stuttgart, Germany
Publications: Int J Womens Health
Document Types: Manuscript in preparation
Countries: Germany, Italy, Spain, UK
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153281/
Condition Year Language Analysis type
Health economics, Pregnancy 2016 English Cost effectiveness
 
 
The costs of managing genital warts in the UK by devolved nation: England, Scotland, Wales and Northern Ireland
Authors: Coles VA, Chapman R, Lanitis T, Carroll SM
Affiliations: Sanofi Pasteur MSD; Evidera
Publications: 
Document Types: Article
Countries: UK
Condition Year Language Analysis type
Health economics, Infectious disease 2016 English Retrospective database analysis
 
 
Health economic burden that different wound types impose on the UK's National Health Service.
Authors: Guest JF, Ayoub N, McIlwraith T, Uchegbu I, Gerrish A, Weidlich D, Vowden K, Vowden P
Affiliations: Catalyst Health Economics Consultants; Faculty of Life Sciences and Medicine, King's College; Bradford Teaching Hospitals NHS Foundation Trust and University of Bradford
Publications: 
Document Types: Article
Countries: UK
Condition Year Language Analysis type
Health economics, Injuries 2016 English Retrospective database analysis
 
 
The daily cost of ICU patients: A micro-costing study in 23 French Intensive Care Units.
Authors: Lefrant JY1, Garrigues B2, Pribil C3, Bardoulat I4, Courtial F4, Maurel F4, Bazin JÉ5; CRREA Study Group; AzuRea Group.
Affiliations: 1Division anesthésie réanimation douleur urgences, faculté de médecine, université Montpellier 1, CHU de Nîmes, place du Professeur-Robert-Debré, 30029 Nîmes cedex 9, France. Electronic address: jean.yves.lefrant@chu-nimes.fr. 2Service de réanimation et de surveillances médico-chirurgicales polyvalentes, centre hospitalier du Pays d'Aix, Aix-en-Provence, France. 3Health Outcomes Department, GlaxoSmithKline, 100, route de Versailles, 78163 Marly-le-Roi cedex, France. 4IMS Health, Health Economics and Outcomes Research Department, Tour Ariane, 5-7, place de la Pyramide, 92088 La Défense cedex, France. 5Service anesthésie réanimation, CHU de Clermont-Ferrand, 1, place Lucile-Aubrac, 63003 Clermont-Ferrand cedex, France.
Publications: Anaesthesia Critical Care and Pain Medicine 2015
Document Types: Article
Countries: France
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/25986476
Condition Year Language Analysis type
Health economics 2015 English Cost analysis, Economic evaluation, Observational study
 
 
Can different primary care databases produce comparable estimates of burden of disease: results of a study exploring venous leg ulceration
Authors: Petherick ES, Pickett KE & Cullum NA
Affiliations: 
Publications: 
Document Types: Article
Countries: UK
Condition Year Language Analysis type
Health economics 2015 English Retrospective database analysis
 
 
Clinical outcomes and cost-effectiveness of three alternative compression systems used in the management of venous leg ulcers
Authors: Guest JF, Gerrish A, Ayoub N, Vowden K & Vowden P
Affiliations: Catalyst
Publications: J Wound Care 24(7):300-10
Document Types: Article
Countries: UK
Abstract: http://www.catalyst-health.co.uk/wound-healing-11.html
Condition Year Language Analysis type
Health economics 2015 English Retrospective database analysis
 
 
An assessment of chemotherapy-induced nausea and vomiting direct costs in three EU countries.
Authors: Turini M1, Piovesana V1, Ruffo P1, Ripellino C2, Cataldo N2.
Affiliations: 1 Helsinn S A., Lugano, Switzerland, 2 IMS Health Information Solutions Medical Research srl, Milan, Italy.
Publications: Drugs Context. 28;4:212285.
Document Types: Article
Countries: France, Germany, Italy
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544273/pdf/dic-4-212285.pdf
Condition Year Language Analysis type
Health economics, Oncology 2015 English Survey research
 
 
A cost-effectiveness evaluation comparing biosimilar Bemfola to Gonal-f for the treatment of infertility in an Italian contest.
Authors: Ripellino C1, Visentin E1, Gizzo S2, Bühler K3
Affiliations: 1 IMS Health Information Solutions Medical Research S.r.l, Milan, Italy 2 University of Padua, padua, Italy 3 Centre for Gynaecology, Endocrinology and Reproductive Medicine, Ulm and Stuttgart, Germany
Publications: ISPOR Annual European Congress. Milan, Italy.
Document Types: Poster
Countries: Italy
Condition Year Language Analysis type
Health economics, Pregnancy 2015 English Cost analysis, Economic evaluation
 
 
Access to New Medicines in Public Drug Plans: Canada and Comparable Countries 2015 Annual Report
Authors: Millson B1, Thiele S1, Zhang Y1, Dobson-Belaire W1, Skinner B2
Affiliations: 1 IMS Health Canada Inc., 16720 Trans-Canada Highway, Kirkland, Quebec H9H 5M3 2 Innovative Medicines Canada, 55 Metcalfe Street, Suite 1220, Ottawa, Ontario K1P 6L5
Publications: Innovative Medicines Canada Annual Report 2016
Document Types: Report
Countries: Canada
Abstract: http://innovativemedicines.ca/wp-content/uploads/2016/05/20160524_Access_to_Medicines_Report_EN_Web.pdf
Condition Year Language Analysis type
Health economics, Health policy 2015 English Review
 
 
Health economic burden that wounds impose on the National Health Service in the UK
Authors: Guest JF, Ayoub N, McIlwraith T, Uchegbu I, Gerrish A, Weidlich D, Vowden K, Vowden P
Affiliations: Catalyst Health Economics Consultants, Northwood,; Bradford Teaching Hospitals NHS Foundation Trust and University of Bradford
Publications: 
Document Types: Article
Countries: UK
Condition Year Language Analysis type
Health economics, Injuries 2015 English Retrospective database analysis
 
 
A cost comparison of long-acting insulin analogs vs NPH insulin-based treatment in patients with type 2 diabetes using routinely collected primary care data from the UK
Authors: Idris I, Gordon J, Tilling C, Vora J
Affiliations: Division of Medical Sciences & Graduate Entry Medicine, University of Nottingham
Publications: 
Document Types: Article
Countries: UK
Condition Year Language Analysis type
Diabetes, Health economics 2015 English Retrospective database analysis
 
 
Big data, advanced analytics and the transformation of healthcare delivery: Practical applications in healthcare research
Authors: Keja J1, Incardona F2, Blunt I3, Rigg J1
Affiliations: 1 Real-World Evidence Solutions & HEOR, IMS Health, London, UK 2 Italian Parliamentary Commission on Medical Errors, and Expert Evaluator, European Commission, Rome, Italy 3 The Nutfield Trust, London, UK
Publications: ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: Symposium
Countries: 
Condition Year Language Analysis type
Health economics 2014 English Real World Data
 
 
Relevance of indirect comparisons in the German early benefit assessment and in comparison to HTA processes in England, France and Scotland
Authors: Lebioda A1, Gasche D2, Dippel F-W3, Theobald K4, Plantör S1
Affiliations: 1 IMS Health,Munich, Germany 2 IMS Health, Barcelona, Spain 3 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 4 Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany
Publications: Health Economics Review, 2014, 4(31)
Document Types: Article
Countries: Germany
Abstract: doi:10.1186/s13561-014-0031-5
Condition Year Language Analysis type
Health economics 2014 English Methodology
 
 
Evidence-based insights in oncology: The journey is only just beginning
Authors: Ghai C
Affiliations: RWE Solutions & HEOR, IMS Health, New York, USA
Publications: AccessPoint, 2014, May; 4(8): 14-20
Document Types: Article
Countries: USA
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss
Condition Year Language Analysis type
Health economics, Oncology 2014 English Real World Evidence
 
 
Patient-reported outcomes assessment
Authors: Crawford B1, Luo N2
Affiliations: 1 Real World Evidence Solutions, Japan & APAC, IMS Health KK, Tokyo, Japan 2 Saw Swee Hock School of Public Health, National University of Singapore, Singapore
Publications: ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014 (short course)
Document Types: Workshop
Countries: 
Abstract: http://www.ispor.org/Event/Index/44
Condition Year Language Analysis type
Health economics 2014 English Real World Evidence
 
 
Cost-effectiveness of asenapine in the treatment of patients with bipolar I disorder with mixed episodes in an Italian context.
Authors: Caresano C1, Di Sciascio G2, Fagiolini A3, Maina G4, Perugi G5, Ripellino C6, Vampini C7.
Affiliations: 1 Department of Psychiatry, Lundbeck Italia S.p.A, Milan, Italy, 2 Department of Psychiatry, Policlinico Hospital, Bari, Italy, 3 Department of Molecular Medicine, University of Siena, Siena, Italy, 4 Department of Neurosciences, University of Torino, Turin, Italy, 5 Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 6 Institute of Behavioural Sciences ‘‘G. De Lisio’’, Pisa, 7 CSD Medical Research S.R.L., Milan, Italy, 8 Department of Mental Health, Ospedale Civile Maggiore, Verona, Italy.
Publications: Adv Ther. 2014 Aug;31(8):873-90. doi: 10.1007/s12325-014-0139-3. Epub 2014 Jul 24
Document Types: Article
Countries: Italy
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25055791
Condition Year Language Analysis type
Health economics, Mental health 2014 English Cost effectiveness
 
 
GOLD guidelines adherence impact on the NHS budget
Authors: Ripellino C, Guasconi A, Heiman F.
Affiliations: Cegedim Strategic Data Medical Research srl
Publications: Farmeconomia. 2014;Vol 15, No 1.
Document Types: Article
Countries: Italy
Abstract: http://journals.edizioniseed.it/index.php/FE/article/view/887
Condition Year Language Analysis type
Health economics, Respiratory disease 2014 English Economic evaluation, Retrospective database analysis
 
 
Prevalence of smoking among patients treated in NHS hospitals in England in 2010/2011: a national audit.
Authors: Szatkowski L, Murray R, Hubbard R, Agrawal S, Huang Y & Britton J
Affiliations: University of Nottingham Division of Epidemiology and Public Health
Publications: Thorax. 2014 Nov 10. pii: thoraxjnl-2014-206285. doi: 10.1136/thoraxjnl-2014-206285
Document Types: Article
Countries: UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25385425
Condition Year Language Analysis type
Health economics, Miscellaneous 2014 English Epidemiological study, Retrospective database analysis
 
 
Understanding the cost of hereditary angioedema in England.
Authors: Helbert M, Holbrook T, MacCulloch A & Mannan A
Affiliations: Manchester Royal Infirmary Immunology
Publications: The European Conference on Rare Diseases and Orphan Products (ECRD); 8th–10th May 2014; Berlin, Germany UK/CIN
Document Types: Poster
Countries: UK
Abstract: http://www.rare-diseases.eu/wp-content/uploads/2013/08/27_t1.pdf
Condition Year Language Analysis type
Dermatology, Health economics 2014 English Retrospective database analysis
 
 
ASHP national survey of pharmacy practice in hospital settings: Prescribing and transcribing-2013
Authors: Pedersen CA, Schneider PJ, Scheckelhoff DJ.
Affiliations: Confluence Health-Central Washington Hospital, Wenatchee, WA
Publications: Am J Health Syst Pharm 2014;71(11):924-942.
Document Types: Article
Countries: 
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=ASHP+national+survey+of+pharmacy+practice+in+hospital+settings%3A+Prescribing+and+transcribing-2013.
Condition Year Language Analysis type
Health economics 2014 English Real World Evidence
 
 
National Health Spending In 2012: Rate Of Health Spending Growth Remained Low For The Fourth Consecutive Year
Authors: Martin AB, Hartman M, Whittle L, Catlin A, Team the NHEA
Affiliations: National Health Expenditure Accounts Team
Publications:  Health Aff 2014;33(1):67-77.
Document Types: Article
Countries: 
Abstract: http://content.healthaffairs.org/content/33/1/67.full
Condition Year Language Analysis type
Health economics 2014 English Retrospective cohort analysis
 
 
The economic burden of dasatinib and nilotinib treatment failure in chronic myeloid leukemia (CML) patients: a real-world analysis
Authors: Pokras SM1, Divino V1, Ferrufino C1, Arnold RJA1, Huang H2
Affiliations: 1 IMS Health, Alexandria, USA 2 ARIAD Pharmaceuticals, Cambridge, USA
Publications: International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual International Meeting. May 20, 2013
Document Types: Poster
Countries: USA
Condition Year Language Analysis type
Health economics 2013 English Economic evaluation
 
 
Powering a new age of outcomes research
Authors: Keja J1, Bonzani I2
Affiliations: 1IMS Health, The Netherlands, 2IMS Health, London, UK
Publications: AccessPoint, May 2013; Vol 3(6); 18-22
Document Types: Article
Countries: 
Abstract: http://issuu.com/ims_heor_publications/docs/rwe_accesspoint_6_-_080513f_epub
Condition Year Language Analysis type
Health economics, Miscellaneous 2013 English Real World Evidence
 
 
Evolution of HTA and pharmaecoeconomic analyses in Latin America
Authors: Arnold R1
Affiliations: 1IMS Health, New York, USA
Publications: AccessPoint, May 2013; Vol 3(6); 44-49
Document Types: Article
Countries: Latin America
Abstract: http://issuu.com/ims_heor_publications/docs/rwe_accesspoint_6_-_080513f_epub
Condition Year Language Analysis type
Health economics, Miscellaneous 2013 English Methodology
 
 
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants in major depressive disorder in Italy.
Authors: Mencacci C1, Aguglia E2, Biggio G3, Cappellari L4, Di Sciascio G5, Fagiolini A6, Maina G7, Tortorella A8, Katz P9, Ripellino C9.
Affiliations: 1 Department of Mental Health Fatebenefratelli Hospital, Milan, Italy, 2 Professor of Psychiatry, Department of Clinical and Molecular Biomedicine, University of Catania, 3 Department of Experimental Biology and Center of Excellence for the Neurobiology of Drug Dependence, University of Cagliari, Italy, 4 Department of Mental Health, Camposampiero Hospital, Padova, Italy, 5 Department of Psychiatry-Policlinico Hospital-Bari-Italy, 6 Department of Molecular Medicine University of Siena and Department of Mental Health, University of Siena Medical Center, 7 Department of Neurosciences, University of Torino, Italy, 8 Department of Mental Health, University of Naples, SUN, Italy, 9 CSD Medical Research Srl, Milan, Italy
Publications: Advances in Therapy. July 2013, Volume 30, Issue 7, pp 697-712.
Document Types: Article
Countries: Italy
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23929174
Condition Year Language Analysis type
Health economics, Mental health 2013 English Cost utility, Economic evaluation, Prospective study, Quality of life
 
 
Analisi farmaco-economica sui costi e la qualità di vita dei pazienti affetti da Disturbo Depressivo Maggiore (DDM) trattati con cura antidepressiva in Italia_ Pharmaco-economic analysis on the costs and quality of life of patients with Major Depressive Disorder (MDD) receiving antidepressant treatment in Italy.
Authors: Pegoraro V, Guasconi A, Mencacci C, Aguglia E, Biggio G, Cappellari L, Di Sciascio G, Fagiolini A, Maina G, Tortorella A, Ripellino C.
Affiliations: Center of Molecular and Genetic Epidemiology, Department of Environmental and Occupational Health, Università degli Studi di Milano and IRCCS Fondazione Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
Publications: Congresso Nazionale SIHTA 2013, Bari
Document Types: Poster
Countries: Italy
Condition Year Language Analysis type
Health economics, Mental health, Neurological disorders 2013 Italian Cost analysis, Economic evaluation, Quality of life, Retrospective database analysis
 
 
C-QUALITY: Cost and Quality-of-Life Pharmacoeconomic Analysis of Antidepressants in Major Depressive Disorder in Italy.
Authors: Ripellino C, Heiman F, Katz P.
Affiliations: CSD Medical Research Milano
Publications: ISPOR Annual European Congress. 2013, Dublin
Value in health
Document Types: Poster
Countries: Italy
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)03318-4/abstract
Condition Year Language Analysis type
Health economics, Mental health 2013 English Cost analysis, Quality of life
 
 
Audit of the effect of relative age on morbidity among children in The Health Improvement Network (THIN) UK data.
Authors: Johnson M, Mook P, Thompson M, Bourke A.
Affiliations: Cegedim
Publications: 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Montreal, Canada
Document Types: Poster
Countries: UK
Abstract: http://csdmruk.cegedim.com/THINBibliography.pdf
Condition Year Language Analysis type
Health economics, Miscellaneous 2013 English Retrospective database analysis
 
 
An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance.
Authors: Zhou X, Murugesan S, Bhullar H, Liu Q, Cai B, Wentworth C & Bate A
Affiliations: Cegedim
Publications: Drug Saf. 2013 Feb;36(2):119-34. doi: 10.1007/s40264-012-0009-3.
Document Types: Article
Countries: UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23329543
Condition Year Language Analysis type
Health economics, Methodology 2013 English Retrospective database analysis
 
 
Exploring the cost and burden of illness of hereditary angioedema in the UK.
Authors: Helbert M, Holbrook T, Drogon E & Mannan A
Affiliations: Adelphi
Publications: UK PIN Liverpool Liverpool, UK 2013
Document Types: Poster
Countries: UK
Abstract: http://csdmruk.cegedim.com/THINBibliography.pdf
Condition Year Language Analysis type
Dermatology, Health economics 2013 English Retrospective database analysis
 
 
Risk identification in Healthcare Records: comparison to epidemiological studies.
Authors: Edwards IR1, Karimi G1, Bergvall T1, Caster O1, Asiimwe A2, Star K1, Bhayat F3, Soriano-Gabarro M4, Thakrar B5, Thompson M6, Bate A7 & Norén GN1
Affiliations: 1 Uppsala Monitoring Centre, Uppsala, Sweden. 2 Eli Lilly UK, Surrey, United Kingdom. 3 Takeda (TGRD), London, United Kingdom. 4 Bayer Pharma AG, Berlin, Germany. 5 F Hoffmann-La Roche, Basel, Switzerland, 6 Cegedim Strategic Data Medical Research Ltd, London, United Kingdom. 7 Pfizer UK, Surrey, United Kingdom 6. Cegedim
Publications: 29th International Conference on Pharma, coepidemiology and Therapeutic Risk Management (ICPE), Montreal, Canada
Document Types: Poster
Countries: UK
Abstract: http://www.imi-protect.eu/documents/IREdwardsetalRiskidentificationinHealthcareRecordscomparisontoepidemiologicalstudiesICPEAug2.pdf
Condition Year Language Analysis type
Health economics, Methodology 2013 English Retrospective database analysis
 
 
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia.
Authors: Mencacci C1, Aguglia E2, Biggio G3, Cappellari L4, Di Sciascio G5, Fagiolini A6, Maina G7, Tortorella A8, Katz P9, Ripellino C9.
Affiliations: 1 Department of Mental Health, Fatebenefratelli Hospital, Milan 2 Department of Clinical and Molecular Biomedicine, University of Catania, Catania 3 Department of Experimental Biology and Center of Excellence for the Neurobiology of Drug Dependence, University of Cagliari, Calgiari 4 Department of Mental Health, Camposampiero Hospital, Padova 5 Department of Psychiatry, Policlinico Hospital, Bari 6 Department of Molecular Medicine, University of Siena and Department of Mental Health, University of Siena Medical Center, Siena 7 Department of Neurosciences, University of Torino, Torino 8 Department of Mental Health, University of Naples SUN, Naples 9 CSD Medical Research Srl, Milan, Italy
Publications: Clinicoecon Outcomes Res. 5:611-21
Document Types: Article
Countries: Italy
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=C-QUALITY%3A+cost+and+quality-of-life+pharmacoeconomic+analysis+of+antidepressants+used+in+major+depressive+disorder+in+the+regional+Italian+settings+of+Veneto+and+Sardinia.
Condition Year Language Analysis type
Health economics, Mental health 2013 English Cost utility, Economic evaluation, Quality of life
 
 
Less spending on prescription drug promotion
Authors: xxx
Affiliations: Massachusetts Institute of Technology
Publications: PharmacoEcon Outcomes News 2013;675(1):8-8
Document Types: Abstract
Countries: 
Condition Year Language Analysis type
Health economics 2013 English Public Health
 
 
AstraZeneca's Real-World Bet
Authors: Upton J.
Affiliations: Pharmaceutical Executive
Publications: Pharmaceutical Executive
Document Types: Article
Countries: UK
Abstract: http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=761326
Condition Year Language Analysis type
Health economics 2012 English Review
 
 
Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine.
Authors: Ikenberg R1, Hertel N2, Moore RA3, Obradovic M4, Baxter G5, Conway P5, Liedgens H4
Affiliations: 1 IMS Health GmbH & Co, Munich, Germany, 2 IMS Health, London, UK, 3 Oxford University, Oxford, UK, 4 Grünenthal GmbH, Aachen, Germany, 5 Grünenthal Ltd, Stokenchurch, UK
Publications: Journal of Medical Economics, 2012, 15(4): 1-13
Document Types: Article
Countries: UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22364286
Condition Year Language Analysis type
Health economics 2012 English Cost effectiveness
 
 
Cost-Effectiveness of Tapentadol in Severe Chronic Pain in Spain: A Cost Analysis of Data From RCTs
Authors: Obradovic M1, Ikenberg R2, Hertel N3, Antoñanzas F4, Gálvez R5, Liedgens H1
Affiliations: 1 Grünenthal GmbH, Aachen, Germany 2 IMS Health Economics and Outcomes Research, Munich, Germany 3 IMS Health Economics and Outcomes Research, London, UK 4 Department of Economics and Business, University of La Rioja, Logroño, Spain 5 Pain and Palliative Care Unit, University Hospital Virgen de las Nieves, Granada, Spain
Publications: Clinical Therapeutics/Volume 34, Number 4, 2012
Document Types: Article
Countries: Spain
Condition Year Language Analysis type
Health economics 2012 English Cost effectiveness
 
 
Learning from global trends in HTA
Authors: Nelson M1, Lee Chan W2
Affiliations: 1IMS Health, Alexandria, USA, 2IMS Health, San Francisco, USA
Publications: AccessPoint, Nov 2012; Vol 3(5); 42-49
Document Types: Article
Countries: 
Abstract: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Services/Pharma%20Commercial%20Effectiveness/Health%20Economics%20_%20Outcomes%20Research/AccessPoint-5-281012%20F.pdf
Condition Year Language Analysis type
Health economics 2012 English
 
 
Adapting global health economic models to emerging markets
Authors: Arnold R1
Affiliations: 1IMS Health, New York, USA
Publications: AccessPoint, Nov 2012; Vol 3(5); 30-36
Document Types: Article
Countries: 
Abstract: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Services/Pharma%20Commercial%20Effectiveness/Health%20Economics%20_%20Outcomes%20Research/AccessPoint-5-281012%20F.pdf
Condition Year Language Analysis type
Health economics 2012 English
 
 
Health economics analysis of pegfilgrastim in the prophylaxis of febrile neutropenia (FN) in Italy.
Authors: G. Rosti 1, M. Lebboroni 1, A. Cerchiari 2, P. Katz 3
Affiliations: 1 Ospedale Regionale Azienda Unità Locale Socio Sanitaria n°9 di Treviso, Oncologia Medica, Treviso, Italy 2 Amgen Dompè SpA, Health Economics, Milano, Italy 3 CSD Medical Research S.r.l, Pharmacoepidemiology & Health Economics, Milano, Italy
Publications: 17th Congress of European Association of Hospital Pharmacists,
Document Types: Poster
Countries: Italy
Abstract: http://ejhp.bmj.com/content/19/2/172.2
Condition Year Language Analysis type
Health economics, Hematology 2012 English Budget impact
 
 
COST-EFFECTIVENESS ANALYSIS OF DEPRESSION IN ITALY.
Authors: Katz P1, Mencacci C, Di Sciascio G, Ripellino C, Heiman F
Affiliations: 1CSD Medical Research Milan
Publications: 15th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Berlin, Germany
Document Types: Poster
Countries: Italy
Abstract: http://www.ispor.org/E6E2C004-9FF1-4F7E-897E-BC292C74DF07/FinalDownload/DownloadId-24780E6AB48005853A097D13F4256DC1/E6E2C004-9FF1-4F7E-897E-BC292C74DF07/publications/value/valueinhealth_volume15_issue7.pdf
Condition Year Language Analysis type
Health economics, Mental health, Neurological disorders 2012 English Cost effectiveness
 
 
Changing paradigms in the long‐term care market
Authors: Laryssa Wozniak, Mahmud Hassan, Dale Benner.
Affiliations: Confluence Health-Central Washington Hospital, Wenatchee, WA
Publications: Intl J of Pharm & Health Mrkt 2012;6(3):267-278.
Document Types: Article
Countries: 
Abstract: http://www.emeraldinsight.com/doi/abs/10.1108/17506121211259421
Condition Year Language Analysis type
Health economics 2012 English Real World Evidence
 
 
The cost per day of intensive care units (ICU) in France : the CRRéa study.
Authors: Garrigues B1, Lefrant JY2, Bazin JE3, Bardoulat I4, Tagdichti K4, Courtial F4, Maurel F4, Pribil C5
Affiliations: 1 CH du Pays d'Aix, Aix-en6provence, France 2 CHU de Nîmes , Nîmes, France 3 CHRU de Clermont-Ferrand, Clermont-Ferrand, France 4 IMS Health, Puteaux, France 5 GSK France, Marly-le-Roi, France.
Publications: Abstract - Presentation PHP75 for the 14th European congress of Ispor 2011
Document Types: Abstract
Countries: France
Condition Year Language Analysis type
Health economics 2011 English Cost analysis, Economic evaluation, Prospective study
 
 
Resource utilisation related to catheter-associated urinary tract infections in Swedish spinal injury patients
Authors: Bruce S1, Löfroth E1, Knutsson B2, Börstell T2, Myrén KJ1.
Affiliations: 1 IMS Consulting Group, Stockholm, Sweden. 2 AstraTech, Mölndal, Sweden.
Publications: ISPOR 14th Annual European Congress, 2010, 5-8 November, Madrid, Spain
Document Types: Poster
Countries: Sweden
Abstract: http://www.ispor.org/congresses/Spain1111/Posters1.aspx
Condition Year Language Analysis type
Health economics, Infectious disease, Urology 2011 English Burden of illness, Cost analysis, Epidemiological study, Retrospective database analysis
 
 
Resource utilisation related to urinary tract infections in Swedish self-catheterisation patients
Authors: Löfroth E1, Bruce S1, Knutsson B2, Börstell T2, Myrén KJ1.
Affiliations: 1 IMS Consulting Group, Stockholm, Sweden. 2 AstraTech, Mölndal, Sweden.
Publications: ISPOR 14th Annual European Congress, 2010, 5-8 November, Madrid, Spain
Document Types: Poster
Countries: Sweden
Condition Year Language Analysis type
Health economics, Infectious disease, Urology 2011 English Burden of illness, Cost analysis, Epidemiological study, Retrospective database analysis
 
 
Beyond Real-World Evidence
Authors: Badia X1, Bergström R2, Keja J3
Affiliations: 1 IMS Consulting Group, Barcelona, Spain; 2 EFPIA, Brussels, Belgium; 3 IMS Consulting Group, London, UK
Publications: ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: Symposium
Countries: 
Condition Year Language Analysis type
Health economics 2011 English Prospective study
 
 
Analisi di budget impact sull’utilizzo di pegfilgrastim nella profilassi della neutropenia febbrile in Italia.
Authors: Rosti G1, Lebboroni M1, Cerchiari A2, Katz P3.
Affiliations: 1 Oncologia Medica, Ospedale Regionale, Azienda Unità Locale Socio Sanitaria n°9 di Treviso, 2 Amgen Dompè SpA, Italia, 3 CSD Medical Research Srl, Italia
Publications: Farmeconomia e percorsi terapeutici. 12(3). 119-127.
Document Types: Article
Countries: Italy
Condition Year Language Analysis type
Health economics, Oncology 2011 Italian Budget impact
 
 
Commercial importation of prescription drugs in the United States: short-run implications
Authors: Danzon PM, Johnson SJ, Long G, Furukawa MF
Affiliations: University of Rochester Medical Center, Rochester
Publications: J Health Polit Policy Law 2011;36(2):295-316.
Document Types: Article
Countries: 
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Commercial+importation+of+prescription+drugs+in+the+United+States%3A+short-run+implications.
Condition Year Language Analysis type
Health economics 2011 English Economic evaluation
 
 
Impacto de la introducción de alitretinoína oral en los costes del eczema de las manos severo de origen profesional desde la perspectiva de las Mutuas de Accidentes de Trabajo y Enfermedades Profesionales en España.
Authors: Manuel Mascaró J, Quero Nasarre I, Lindner L, Prior M, Oliver J, Halbach R.
Affiliations: Manuel Mascaró J1, Quero Nasarre I2, Lindner L3, Prior M3, Oliver J4, Halbach R4. 1Servicio de Dermatología, Hospital Clínic de Barcelona. 2Servicio de Dermatología. MAZ de Zaragoza. 3IMS Health. 4Basilea Pharmaceuticals Iberia, S. L.
Publications: Rev. SEMST 2010; 5(1): 9-18
Document Types: Article, Manuscript in preparation
Countries: Spain
Abstract: http://dialnet.unirioja.es/servlet/articulo?codigo=3161177
Condition Year Language Analysis type
Dermatology, Health economics 2010 Spanish Cost analysis, Cost consequence
 
 
Agreements with pharmaceutical industry: “Paying pay for results”
Authors: Badia X, Prior M.
Affiliations: 
Publications: Farm Hosp.2010;34(2):53–55.
Document Types: Article
Countries: Spain
Abstract: http://www.sefh.es/fh/105_121v34n02pddf001.pdf
Condition Year Language Analysis type
Health economics 2010 Spanish Cost effectiveness
 
 
Regionalization of Market research. Why should it be evidence-based.
Authors: Badia X, Sabater J.
Affiliations: 
Publications: PM Farma 2010;XVII(105):54-55.
Document Types: Article
Countries: Spain
Condition Year Language Analysis type
Health economics 2010 Spanish Cost analysis
 
 
Healthcare utilisation after platelet aggregation inhibitors.
Authors: Löfroth E, Myrén KJ, Bruce S.
Affiliations: IMS Health, Stockholm, Sweden.
Publications: ISPOR 13th Annual European Congress, 2010, 6-9 November, Prague, Czech Republic
Document Types: Poster
Countries: Sweden
Abstract: http://www.ispor.org/congresses/Prague1110/posters2.aspx
Condition Year Language Analysis type
Health economics 2010 English Retrospective database analysis
 
 
Prevalence of affective disorders in South-West region of Sweden.
Authors: Löfroth E, Myrén KJ, Bruce S, Dahlberg E.
Affiliations: IMS Health, Stockholm, Sweden.
Publications: ISPOR 13th Annual European Congress, 2010, 6-9 November, Prague, Czech Republic
Document Types: Poster
Countries: Sweden
Abstract: http://www.ispor.org/congresses/Prague1110/posters3.aspx
Condition Year Language Analysis type
Health economics 2010 English Retrospective database analysis
 
 
Healthcare utilisation of major depressive disorder patients.
Authors: Myrén KJ, Löfroth E, Dahlberg E.
Affiliations: IMS Health, Stockholm, Sweden.
Publications: ISPOR 13th Annual European Congress, 2010, 6-9 November, Prague, Czech Republic
Document Types: Poster
Countries: Sweden
Condition Year Language Analysis type
Health economics 2010 English Retrospective database analysis
 
 
Cost impact of initiating pregabalin treatment in Swedish patients with generalized anxiety disorder.
Authors: Löfroth E1, Myrén KJ1, Sandelin R2.
Affiliations: 1. IMS Health, Stockholm, Sweden. 2. Pfizer AB, Sollentuna, Sweden.
Publications: ISPOR 13th Annual European Congress, 2010, 6-9 November, Prague, Czech Republic
Document Types: Poster
Countries: Sweden
Abstract: http://www.ispor.org/congresses/Prague1110/posters3.aspx
Condition Year Language Analysis type
Health economics 2010 English Retrospective database analysis
 
 
Cost impact from initiating pregabalin treatment in patients with refractory neuropathic pain.
Authors: Myrén KJ1, Löfroth E1, Sandelin R2.
Affiliations: 1. IMS Health, Stockholm, Sweden. 2. Pfizer AB, Sollentuna, Sweden.
Publications: ISPOR 13th Annual European Congress, 2010, 6-9 November, Prague, Czech Republic
Document Types: Poster
Countries: Sweden
Abstract: http://www.ispor.org/congresses/Prague1110/posters3.aspx
Condition Year Language Analysis type
Health economics 2010 English Retrospective database analysis
 
 
Assessment of the workload real time dedicated to each patient in intensive care units (ICU): preliminary results of the CRREA study
Authors: Garrigues B (1), Lefrant JY (2), Bazin JE (3), Probil C (4), Maurel F(5)
Affiliations: 1. CH du Pays d'Aix, Aix en Provence, France 2. CHU de Nïmes, Nïmes, France 3. CHRU de Clermont-Ferrand, Clermont-Ferrand, France 4. GSK France, Marly-Le-Roi, France 5. IMS Health, Puteaux, France
Publications: ISPOR 13th Annula European Congress to be held 6-9 November 2010 at the Prague Congress Centre in Prague, Czech Republic
Document Types: Abstract, Poster
Countries: France
Condition Year Language Analysis type
Health economics 2010 English Cost analysis
 
 
Quel est le temps réellement consacré à chaque patient en service de réanimation? résultats préliminaires de l'étude CRRéA
Authors: Lefrant JY (1), Bazin JE (2), Pribil C (3), Maurel F (4), Gariigues B (5)
Affiliations: 1. CHU de Nîmes, Nîmes, France 2. CHRU de Clermont-Ferrand, Clermont Ferrand, France 3. GSK France, Marly-Le-Roi, France 4. IMS Health, Puteaux, France 5. CH du pays d’Aix, Aix-en-Provence, France
Publications: SFAR 2010, Congrès national d'anesthésie et de réanimation du 22 au 25 septembre 2010 - session Médecine d'urgence 2
Document Types: Abstract, Oral presentation
Countries: France
Condition Year Language Analysis type
Health economics 2010 French Cost analysis, Observational study
 
 
Cost-effectiveness of tapentadol prolonged-release (PR) compared to oxycodone and morphine in patients with chronic moderate to severe non-cancer pain in Sweden
Authors: Hertel N1, Ikenberg R1, Fricke FU12, Liedgens H3
Affiliations: 1IMS Health, Nuremberg, Germany 2Georg Simon Ohm University of Applied Sciences, Nuremberg, Germany 3Gruenenthal GmbH, Aachen, Germany
Publications: ISPOR November 6-9, 2010 Prague, Czech Republic
Document Types: Abstract
Countries: Sweden
Condition Year Language Analysis type
Health economics, Musculoskeletal disease 2010 English Cost benefit
 
 
A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit*
Authors: Dasta JF, Kane-Gill SL, Pencina M, et al
Affiliations: University of Miami, Florida
Publications:  Critical Care Medicine 2010;38(2):497-503
Document Types: Abstract
Countries: 
Abstract: http://journals.lww.com/ccmjournal/Abstract/2010/02000/A_cost_minimization_analysis_of_dexmedetomidine.20.aspx
Condition Year Language Analysis type
Health economics 2010 English Cost minimization
 
 
Characterizing Markets for Biopharmaceutical Innovations: Do Biologics Differ from Small Molecules?
Authors: Trusheim MR, Aitken ML, Berndt ER.
Affiliations: Massachusetts Institute of Technology
Publications: Forum for Health Economics & Policy. Jul 2010; 13(1) 1558-9544.
Document Types: Book
Countries: 
Abstract: http://www.degruyter.com/dg/viewarticle/j$002ffhep.2010.13.1$002ffhep.2010.13.1.1200$002ffhep.2010.13.1.1200.xml
Condition Year Language Analysis type
Health economics 2010 English Public Health
 
 
Using Early Economic Modelling to inform strategic pricing and clinical study design
Authors: Lloyd A1, Chambers M2, Caputo J1
Affiliations: 1 IMS Health, London, UK 2 GlaxoSmithKline, Uxbridge, UK
Publications: ISPOR 12th Annual European Congress, Paris France 24-27th October 2009
Document Types: Workshop
Countries: UK
Condition Year Language Analysis type
Health economics 2009 English Workshop
 
 
Verbrauch von Erythropoese-stimulierenden Faktoren in der Therapie der renalen Anämie - eine „real life“- Analyse der Versorgungssituation in Deutschland [Consumption of erythropoietin-stimulating factors in the renal anaemia therapy - a "real life"-analysis of the German medical treatment situation]
Authors: Schöffski O1, Müller H-J2, Kostev K3, Claus V4
Affiliations: 1 University Erlangen-Nuremberg, Nuremberg, Germany 2 Med. Klinik III Klinikum Fulda gAG, Fulda, Germany 3 IMS Health, Frankfurt, Germany 4 IMS Health, Munich, Germany
Publications: Congress for nephrology, Göttingen, Germany, 26-29 September 2009
Document Types: Abstract, Poster
Countries: Germany
Condition Year Language Analysis type
Health economics, Hematology, Nephrology 2009 German Retrospective database analysis
 
 
[Coste-efectividad de la identificación genética en pacientes en tratamiento con acenocumarol] Genotyping in patients in treatment with acenocumarol cost-effectiveness.
Authors: Lindner L, Lara N, Tàssies D, Tejedor D, Jofre-Monseny L
Affiliations: Lindner L1, Lara N1, Tàssies D2, Tejedor D3, Jofre-Monseny L3. 1Health Economics & Outcomes Research - IMS Health; 2Servicio de Hemoterapia y Hemostasia.Hospital Clínic Barcelona. 3 Progenika Biopharma S.A
Publications: 
Document Types: Article, Manuscript in preparation
Countries: Spain
Condition Year Language Analysis type
Health economics, Hematology 2009 Spanish Cost effectiveness
 
 
Publication trends of budget impact analyses over the past six years.
Authors: Pathak P, Kowal-Podmore S, Munakata J
Affiliations: 
Publications: ISPOR 14th International Meeting
Document Types: Poster
Countries: USA
Condition Year Language Analysis type
Health economics 2009 English Literature Review
 
 
Complex Attention-Deficit/Hyperactivity Disorder: Patient Characteristics, Health Care Utilization And Costs In A Retrospective Observational Claims Study
Authors: Hess G1, Sasane R2, Hill J1, Hodgkins P2, Shah MR1
Affiliations: 1IMS Health, former SDI Health, Plymouth Meeting, PA, USA, 2Shire Pharmaceuticals, Wayne, PA, USA
Publications: Value in Health Volume 12, Issue 7 , Page A361, October 2009
Document Types: Article
Countries: 
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)74773-2
Condition Year Language Analysis type
Health economics, Pediatrics, Pricing and reimbursement 2009 English Cost analysis, Cost utility, Observational study
 
 
The importance of clinical variables in comparative analyses using propensity-score matching: the case of ESA costs for the treatment of chemotherapy-induced anaemia.
Authors: Polsky D1, Eremina D2, Hess G12, Hill J2, Hulnick S2, Roumm A2, Whyte JL3, Kallich J3
Affiliations: 1University of Pennsylvania, Philadelphia, PA, USA, 2IMS Health (Former SDI Health),Plymouth Meeting, PA, USA, 3Amgen Inc., Thousand Oaks, California, USA
Publications: Pharmacoeconomics. 2009;27(9):755-65
Document Types: Article
Countries: 
Abstract: http://link.springer.com/article/10.2165%2F11313860-000000000-00000
Condition Year Language Analysis type
Health economics, Hematology 2009 English Cost analysis, Cost effectiveness, Quality of life
 
 
Cost-effectiveness analysis of smoking cessation pharmacotherapies in Australia
Authors: Bhatti T, Makino K, Guarnieri C, Gordois A, Cotter T, Perez D, Bishop J, Glass P
Affiliations: 
Publications: ISPOR 3rd Asia-Pacific Conference, Seoul, Korea, September 2008
Document Types: Poster
Countries: Australia
Condition Year Language Analysis type
Health economics 2008 English Cost effectiveness
 
 
Eficiency and drugs: Review of Guidelines for Economic Evaluation
Authors: Del Llano J, Pinto JL, Abellán JM, Barbieri M, Polanco C
Affiliations: 
Publications: La Cuarta Garantía. Sanofi-aventis, Barcelona (2008). ISBN: 978-84-691-2988-3
Document Types: Book
Countries: 
Condition Year Language Analysis type
Health economics 2008 Spanish Economic evaluation
 
 
Modelo de impacto presupuestario de la administración de darbepoetina alfa cada 3 semanas comparado con la administración de epoetina alfa y epoetina beta 3 veces por semana y semanalmente en pacientes con anemia inducida por quimioterapia [Budget impact model of darbepoetin alfa administered once every three weeks relative to epoetin alfa and beta administered three times per week or weekly in patients with chemotherapy induced anaemia]
Authors: Pérez-Alcántara F1, Badia Llach X1, Riera Febrer M1, Vieta Salomó A1, Arocho R2
Affiliations: 1IMSHealth®; 2Amgen S.A.
Publications: Revista Española de Economía de la Salud 2008; 7(1):41-48
Document Types: Article
Countries: Spain
Condition Year Language Analysis type
Health economics 2008 Spanish Cost consequence
 
 
Economic assessment of controlled-release Oxycodone for the treatment of chronic pain
Authors: Gálvez Mateos R, Camps Herrero C, Lara Suriñach N, Polanco Sánchez C
Affiliations: 
Publications: Rev Esp Econ Salud 2008;7(4):157-164
Document Types: Article
Countries: Spain
Condition Year Language Analysis type
Health economics 2008 Spanish Economic evaluation
 
 
Impacto sociosanitario en pacientes con enfermedades raras (estudio ERES) [Sociosanitary impact on patients with rare diseases (ERES study)]
Authors: Avellaneda Fernández A1,2, Layola M3, Izquierdo Martínez M1,4, Guilera M3, Badia Llach X3, Ramón JR1
Affiliations: 1Instituto de Investigación de Enfermedades Raras (IIER). Instituto de Salud Carlos III. Madrid. 2Centro Sanitario Los Cármenes. Comunidad de Madrid. Madrid. 3Grupo Health Outcomes Research Europe (Grupo HOR-Europe). 4Servicio de Análisis e Intervención en Salud Pública. Dirección General de Salud Pública y Alimentación. Comunidad de Madrid. Madrid. España.
Publications: Medicina Clinica 2007;129(17):646-51
Document Types: Article
Countries: Spain
Condition Year Language Analysis type
Health economics 2008 Spanish Market impact
 
 
Global and Spanish Pharmaceuticals market trends
Authors: Prior M
Affiliations: 
Publications: The 28th days on Health economics: economics, behaviour and health, Salamanca 28-30 may 2008
Document Types: Oral presentation
Countries: Spain
Condition Year Language Analysis type
Health economics 2008 Spanish
 
 
Retos en la evaluación económica de productos oncológicos [Challenges in economic evaluation of oncological products]
Authors: Badia X1
Affiliations: 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: Summer School of pharmacoeconomics: Economic evaluation of health intervention 2008 May 18-19, Granada, Spain
Document Types: Oral presentation
Countries: Spain
Condition Year Language Analysis type
Health economics 2008 Spanish Economic evaluation
 
 
Regional market access inequalities for new oncology drugs in Spain
Authors: Vieta A1, Gimenez E1, Badia X1
Affiliations: 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece
Document Types: Oral presentation
Countries: Spain
Condition Year Language Analysis type
Health economics 2008 English
 
 
Pharmabetriebslehre [Business operations in the pharmaceutical industry]
Authors: Schöffski O1, Fricke F-U2, Guminski W3 (ed.)
Affiliations: 1 University Erlangen-Nuremberg, Germany 2 IMS Health, Nuremberg, Germany 3 TNS Healthcare, Munich, Germany
Publications: Berlin-Heidelberg, Springer, Second edition
Document Types: Book
Countries: 
Condition Year Language Analysis type
Health economics 2008 German Methodology
 
 
Die pharmazeutische Industrie und der Arzneimittelmarkt [Pharmaceutical industry and drug market]
Authors: Fricke F-U1, Schöffski O2
Affiliations: 1 IMS Health, Nuremberg, Germany 2 University Erlangen-Nuremberg, Germany
Publications: Schöffski O, Fricke F-U, Guminski W (ed.). Pharmabetriebslehre, Berlin-Heidelberg, Springer, 2008, 23-46
Document Types: Book chapter
Countries: 
Condition Year Language Analysis type
Health economics 2008 German Methodology
 
 
Pharmacotherapy evaluation: Drugs that assist smoking cessation
Authors: Perez D, Cotter T, Makino K, Bhatti T, Gordois A, Guarnieri C, Lewis S, Glass P, Bishop J
Affiliations: 
Publications: Sydney: Cancer Institute NSW
Document Types: Report
Countries: Australia
Condition Year Language Analysis type
Health economics 2008 English Economic evaluation
 
 
Health economics review of bowel cancer in Australia
Authors: Bishop J, Glass P, Tracey E, Hardy M, Warner K, Makino K, Gordois A, Wilson J, Guarnieri C, Feng J, Sartori L
Affiliations: 
Publications: NSW Cancer Institute, Sydney
Document Types: Review
Countries: Australia
Condition Year Language Analysis type
Health economics 2008 English Cost effectiveness
 
 
Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach.
Authors: Hass B1, Lungershausen J1, Hertel N1, Kotowa W1, Poulsen Nautrup B2, Liedgens H3
Affiliations: 1 IMS Health, Nuremberg, Germany 2 EAH-Consulting, Juelich, Germany 3 Gruenenthal GmbH, Aachen, Germany
Publications: The European journal of health economics, 21. Dezember 2008
Document Types: Online article
Countries: Germany
Condition Year Language Analysis type
Health economics, Musculoskeletal disease 2008 English Cost effectiveness
 
 
Estimated costs associated with different fracture risks related to opioid treatment in Germany
Authors: Kotowa W1, Völkl M1, Hass B1, Poulsen Nautrup B2
Affiliations: 1 IMS Health, Nuremberg, Germany 2 EAH Consulting, Juelich, Northrhine Westf
Publications: ISPOR 12th Annual International Meeting 2007, May 19-23, Arlington, VA, USA
Document Types: Abstract, Oral presentation
Countries: Germany
Condition Year Language Analysis type
Health economics 2007 English Cost effectiveness
 
 
From evidence-based medicine to health outcomes research:an approach to reality
Authors: Badia X, Lizán L.
Affiliations: 
Publications: Rev Esp Econ Salud 2007;6(1):42-44
Document Types: Manuscript in preparation
Countries: Spain
Condition Year Language Analysis type
Health economics 2007 Spanish Methodology
 
 
Economic evaluations in pricing and reimbursement process of pharmaceutical products in Europe
Authors: Vieta A, Lara N, Badia X
Affiliations: 
Publications: XXVII Jornadas de Economía de la Salud (AES). La Coruña 6-8 June
Document Types: Oral presentation
Countries: Europe
Condition Year Language Analysis type
Health economics 2007 Spanish Pricing & Reimbursement
 
 
A cross-sectional validation of the mini-HIV questionnaire
Authors: Pedrol E, Ortega E, Sanz J, Suárez-Lozano I, Perulero N, García Pulgar MS, Escayola R
Affiliations: 
Publications: 
Document Types: Poster
Countries: Spain
Condition Year Language Analysis type
Health economics 2007 English Quality of life
 
 
The impact of different resource cost definitions on results, interpretations, and comparability of health economic studies
Authors: Tunis SL1, Pelletier EM2, St. Charles M1, McEwan P3.
Affiliations: 1IMS Health, Noblesville, IN, USA, 2IMS Health, Watertown, MA, USA, 3Cardiff Medicentre, University Hospital of Wales, Cardiff, UK
Publications: ISPOR 10th Annual European Meeting, 2007, October, Dublin, Ireland
Document Types: Workshop
Countries: USA
Condition Year Language Analysis type
Health economics, Methodology 2007 English Methodology, Retrospective database analysis
 
 
European databases and retrospective database analysis
Authors: Elise Pelletier; Erik Spaepen
Affiliations: 
Publications: ISPOR 2007 10th Annual European Congress
Document Types: 
Countries: Europe
Condition Year Language Analysis type
Health economics 2007 English Review
 
 
Der gesundheitspolitische Nutzen von Evaluationsstudien [The health-political benefit of evaluation-surveys]
Authors: Fricke FU
Affiliations: IMS Health, Nuremberg, Germany
Publications: Schoeffski O, v. d. Schulenburg JM (ed.): Gesundheitsökonomische Evaluationen, 3. vollständig überarbeitete Auflage, Berlin-Heidelberg, Springer, 2007, 509-534
Document Types: Book chapter
Countries: 
Condition Year Language Analysis type
Health economics 2007 German Pricing & Reimbursement
 
 
Field Research
Authors: Pirk O1, Claes C2, Schöffski O2
Affiliations: 1 IMS Health, Nuremberg, Germany 2 Forschungsstelle für Gesundheitsökonomie und Gesundheitssystemforschung, Universität Hannover
Publications: Schoeffski O, v. d. Schulenburg JM (ed.): Gesundheitsökonomische Evaluationen, 3. vollständig überarbeitet Auflage, Berlin-Heidelberg, Springer, 2007, 201-260
Document Types: Book chapter
Countries: 
Condition Year Language Analysis type
Health economics 2007 German
 
 
The spectrum OF health care costs associated WITH herpes zoster: acute pain vs. postherpetic neuralgia
Authors: Hawkins K, White R, Dworkin R, O'connor A, Baser O
Affiliations: 
Publications: ISPOR 12th Annual International Meeting, May 19-23, 2007
Document Types: Poster
Countries: USA
Abstract: http://www.ispor.org/research_study_digest/details.asp
Condition Year Language Analysis type
Health economics 2007 English
 
 
Patient transfer decrease and health insurance costs savings associated with telemedicine consultation. Example of the telemedicine network of “midi-pyrénées” (RTR)
Authors: LARENG L; SALVODELLI M; BILLON S; BOURGUIGNON S; LECLERCQ C.
Affiliations: 
Publications: ISPOR 2007 10th Annual European Congress
Document Types: 
Countries: 
Condition Year Language Analysis type
Health economics 2007 English
 
 
Conjoint analysis a technique to develop a questionnaire of treatment preferences in patients with lung cancer
Authors: Perulero N, Cardenal F, Garcia R, Juan O, Vázquez S, Barneto I, Varela C
Affiliations: 
Publications: 
Document Types: Poster
Countries: Spain
Condition Year Language Analysis type
Health economics 2007 English Quality of life
 
 
Patients with myelodysplastic syndromes (MDS) challenge transfusion resources now and in the future
Authors: Plesnila Frank C, Rottenkolber D, Berger K
Affiliations: 
Publications: ISPOR 2007 10th Annual European Congress
Document Types: 
Countries: Germany
Condition Year Language Analysis type
Health economics 2007 English
 
 
Evaluación económica de medicamentos biotecnológicos: retos y oportunidades [Economic Evaluation of biotechnological drugs: challenge and opportunities]
Authors: Badia Llach X, Polanco Sánchez C
Affiliations: 
Publications: Rev Esp Econ Salud 2007;6(6):352-7
Document Types: Article
Countries: Spain
Condition Year Language Analysis type
Health economics 2007 Spanish Economic evaluation
 
 
Is the regulation of the pharmaceutical market justified?
Authors: Vieta A
Affiliations: 
Publications: Rev Esp Econ Salud 2007;6(5):278-81
Document Types: Article
Countries: Spain
Abstract: http://www.economiadelasalud.com/Ediciones/65/08_pdf/regulation.pdf
Condition Year Language Analysis type
Health economics 2007 Spanish
 
 
The cost of zoster and post-herpetic neuralgia treatment in France.
Authors: Loock J, Le Pen C, Baptiste C, Bloch K, Valentin E, Bruxelle J, Berrut G, Gallais JL, Stahl JP
Affiliations: 
Publications: ISPOR
ISPOR 2007 10th Annual European Congress
Document Types: Abstract, Oral presentation
Countries: France
Condition Year Language Analysis type
Dermatology, Health economics 2007 English Burden of illness
 
 
The relative cost-effectiveness of the fentanyl HCL patient-activated transdermal system (ITS) in acute post-operative pain management (POPM) in Greece.
Authors: Yfantopoulos I, Papanicolaou S, Papagiannopoulou V, Van Bellinghen LA, Annemans L
Affiliations: 
Publications: ISPOR 10th Annual European Congress, 2007, October 20-23, Dublin, Ireland
ISPOR 2007 10th Annual European Congress
Document Types: Abstract
Countries: Belgium, Greece
Condition Year Language Analysis type
Clinical practice, Health economics 2007 English Cost effectiveness
 
 
The impact of different resource cost definitions on results, interpretations, and comparability of health economic studies.
Authors: Tunis SL1, Pelletier EM1, St. Charles M1, McEwan P2
Affiliations: 1IMS Health, Inc., Watertown, MA, USA, 2
Publications: International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 10th Annual European Meeting, Dublin, Ireland, October 2007
Document Types: Workshop
Countries: USA
Condition Year Language Analysis type
Health economics, Methodology, Miscellaneous 2007 English Retrospective database analysis
 
 
The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks.
Authors: Van Staa TP, Kanis JA, Geusens P, Boonen A, Leufkens HG & Cooper C
Affiliations: Utrecht University, Utrecht, The Netherlands
Publications: Value Health. 2007 Sep-Oct;10(5):348-57.
Document Types: Abstract, Article
Countries: UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17888099
Condition Year Language Analysis type
Health economics, Womens Health 2007 English Retrospective database analysis
 
 
EL NUEVO PACIENTE: Los retos de la información sobre salud y medicamentos [The new patient, Information challenges on health and drugs]
Authors: Badia X, Valentín C
Affiliations: 
Publications: Madrid: MSD y Defensor del Paciente de la Comunidad de Madrid; 1st ed. Madrid 2006:13-58
Document Types: Book chapter
Countries: 
Condition Year Language Analysis type
Health economics 2006 Spanish
 
 
Use of EQ-5D questionnaire in economic evaluations
Authors: Betegón L,. Lara N, Badia X.
Affiliations: 
Publications: XXVII Jornadas de Economía de la Salud (AES). La Coruña 6-8 June
Document Types: Poster
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 Spanish Economic evaluation
 
 
Carer's perspective ON the valuation OF schizophrenia-related health states USING the assessment OF quality OF life questionnaire AND the EQ5D
Authors: Adams J, Le Reun C, Crowley S, Eggleston A
Affiliations: 
Publications: 
Document Types: Oral presentation
Countries: Australia
Condition Year Language Analysis type
Health economics 2006 English Quality of life
 
 
Review of the use of the EQ5D in cost-utility analysis.
Authors: Betegón L, Badia X.
Affiliations: 
Publications: EuroQol Group Scientific Meeting 2006, Barcelona (Spain) 14-15 September
Document Types: Oral presentation
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 English Review
 
 
Review of the use of the Proxy version of the EQ-5D.
Authors: Lara N, Badia X.
Affiliations: 
Publications: EuroQol Group Scientific Meeting 2006, Barcelona (Spain) 14-15 September
Document Types: Oral presentation
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 English Review
 
 
Towards a better QALY model.
Authors: Abellán-Perpiñán J.M., Pinto-Prades J.L., Méndez-Martínez I, Badia Llach X.
Affiliations: 
Publications: Health Econ 2006;15:665-76
Document Types: Manuscript in preparation
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 English Quality of life
 
 
When the direct to patient information in health and prescription drugs is already a fact through Internet.
Authors: Badia Llach X, Alonso-Rodríguez Piedra N.
Affiliations: 
Publications: Rev Esp Econ Salud 2006;5(5):272-5
Document Types: Manuscript in preparation
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 English
 
 
The new patient: the challenges of health and drugs information.
Authors: Badia X, Valentín C.
Affiliations: H.O.R. Europe, a unit of IMS
Publications: Madrid: MSD y Defensor del Paciente de la Comunidad de Madrid; 1st ed Merck Sharp & Dohme de España S.A, Madrid 2006;13-58
Document Types: Manuscript in preparation
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 English Review
 
 
Visados de inspección: ¿garantía del uso adecuado de los medicamentos o medida de control del gasto?
Authors: Gutiérrez Nicuesa L, Magaz Marqués S, Badia Llach X.
Affiliations: 
Publications: Aten Prim;37(5):278-86
Document Types: Manuscript in preparation
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 Spanish
 
 
The Role of Pharmacoeconomics in US Managed Care Formulary Decisions: A Case Study
Authors: Minshall M
Affiliations: 
Publications: Pharma Pricing & Reimbursement, February 2007, pp46-50
Document Types: Manuscript in preparation
Countries: USA
Condition Year Language Analysis type
Health economics 2006 English
 
 
Assessment of the economic value of the INTERCEPT Blood System in Belgium.
Authors: Moeremans K; Annemans L.
Affiliations: 
Publications: Transfusion Medicine, 2006; 16:17-30
Document Types: Manuscript in preparation
Countries: Belgium
Condition Year Language Analysis type
Health economics 2006 English
 
 
Is it efficient to inform the patient about the new drugs? An economic model for Spain.
Authors: Badia X.
Affiliations: 
Publications: Forum on ""New challenges for the patients"", Madrid (Spain) 25 October
Document Types: Oral presentation
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 English
 
 
Socioeconomic perspective of patient information.
Authors: Badia X.
Affiliations: 
Publications: Health Law Congress, Madrid (Spain) 19-20 October
Document Types: Oral presentation
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 English
 
 
Health outcomes research: economic evaluation of pain.
Authors: Badia X.
Affiliations: 
Publications: VI expert meeting on socioeconomic issues of pain. Salamanca (Spain) 25 September
Document Types: Oral presentation
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 English
 
 
Economic evaluation in Spain: current situation.
Authors: Badia X.
Affiliations: 
Publications: VI Jornada de Seminarios. Health Economics (Revista Española de Economía de la Salud, IESE, Fundamed), Madrid (Spain) 26 October
Document Types: Oral presentation
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 English
 
 
Health-related quality of life in Outcomes Research.
Authors: Badia X.
Affiliations: 
Publications: VIII Jornadas Conjuntas de las Áreas 9 y 10 de Atención Primaria. The expectations and the achievements: we measure what we do or we do what we measure?, Getafe (Spain) 11 May
Document Types: Oral presentation
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 English
 
 
Patient-Reported Outcomes (PRO).
Authors: Badia X.
Affiliations: 
Publications: XXIV Congreso de la Sociedad Española de Calidad Asistencial (Spanish Society of Quality in Assitance), Toledo (Spain) 24-27 October
Document Types: Oral presentation
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 English
 
 
Extension and implications of Health Outcomes Research(HOR).
Authors: Badia X.
Affiliations: 
Publications: XXIV Congreso of the Sociedad Española de Calidad Asistencial (Spanish Society of Quality in Assitance), Toledo (Spain) 24-27 October
Document Types: Oral presentation
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 English
 
 
Premature mortality associated to obesity in Spain: Adjusted Life Years.
Authors: Betegón L, Oliva J, Echevarria A, Badia X.
Affiliations: 
Publications: XXVI Jornadas de Economía de la Salud (Spanish Association on Health Economy, AES), Toledo (Spain) 23-26 May
Document Types: Oral presentation
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 English
 
 
Recent policy initiatives in the Australian national reimbursement system that have reduced cost dramatically
Authors: Peter Davey.
Affiliations: 
Publications: ISPOR 11th Annual International Meeting
ISPOR 11th International Meeting, 20-24 May 2006 Philadelphia, Pennsylvania, USA. Podium presentation.
Document Types: Oral presentation
Countries: Australia
Condition Year Language Analysis type
Health economics, Health policy 2006 English Pricing & Reimbursement
 
 
Assessing quality of life of rare diseases patients in Spain. ERES STUDY.
Authors: Badia X, Layola M, Pérez P, Avellaneda A, Izquierdo M.
Affiliations: 
Publications: 13th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Lisbon (Portugal) 11-14 October
Document Types: Poster
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 English
 
 
Economic advantages and time savings of using oxaliplatin concentrated solution versus osaliplatin lyophilised powder for infusion
Authors: Favier B, Spath HM, Anhoury P, Pacull A
Affiliations: 
Publications: 
Document Types: Poster
Countries: France
Condition Year Language Analysis type
Health economics 2006 English
 
 
Validation of the patient’s attitudes and perceptions towards HAART questionnaire.
Authors: Fumaz C, Knobel H, Segador A, Lorenzo A, González J, García Pulgar M, Badia X, Perulero N.
Affiliations: 
Publications: 
Document Types: Poster
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 English
 
 
Patients and physicians perceptions towards subcutaneous treatment.
Authors: Knobel H, Fumaz CR, Segador A, Lorenzo A, González J, García Pulgar M, Perulero N.
Affiliations: 
Publications: 8th International Congress on Drug Therapy in HIV Infection, Glasgow (UK) 12-16 November
Document Types: Poster
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 English
 
 
Estimating utility in rotavirus gastroenteritis in children under five in the UK
Authors: Martin A, Cotrell S
Affiliations: 
Publications: 
Document Types: Poster
Countries: UK
Condition Year Language Analysis type
Health economics 2006 English
 
 
An observational health-economic analysis of the treatment of patients with voriconazole in a real-life setting
Authors: Van Campenhout H, De Mees V, Marbaix S, Annemans L
Affiliations: 
Publications: 
Document Types: Poster
Countries: Belgium
Condition Year Language Analysis type
Health economics 2006 English
 
 
Auswirkungen der Gesundheitsökonomie in Industrie und Politik [Effects of Health Economy in Industry and Politics]
Authors: Fricke F-U
Affiliations: IMS Health, Nuremberg, Germany
Publications: Daumann F. et al.: Wettbewerb und Gesundheitswesen: Konzeption und Felder ordnungsökonomischen Denkens, Budapest, 2006, 335-344
Document Types: Book chapter
Countries: Germany
Condition Year Language Analysis type
Health economics 2006 German
 
 
Quantifying the impact of fear of hypoglycaemia on quality of life
Authors: Walters N, Gordois A, Brown A, Lindsay P, Gonzalo F, Comas S
Affiliations: 
Publications: ISPOR 9th Annual European Congress
Document Types: Poster
Countries: Australia
Condition Year Language Analysis type
Diabetes, Health economics 2006 English Burden of illness
 
 
When Direct-to-Patient health and prescription drug information is already a reality through the Internet.
Authors: Badia X, Alonso-Rodríguez Piedra N
Affiliations: 
Publications: Rev Esp Econ Salud 2006;5(5):272-5
Document Types: Article
Countries: Spain
Condition Year Language Analysis type
Health economics 2006 Spanish
 
 
A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease.
Authors: Lamotte M, Annemans L, Evers T, Kubin M
Affiliations: 
Publications: Pharmacoeconomics, 2006, 24(2): 155-169
Pharmacoeconomics; 24:155-69
Document Types: Article, Manuscript in preparation
Countries: Belgium
Condition Year Language Analysis type
Cardiovascular disease, Health economics 2006 English Economic evaluation
 
 
Economic evaluation of surgical treatment vs. Imiquimod 5% cream in patients with Superficial Basal Cell Carcinoma
Authors: Vanaclocha F, Badia X, Guillén V, Sánchez J, Sáinz de los Terreros M, Llorens MA.
Affiliations: 
Publications: Br J Dermatol. 2007 Apr;156(4):769-71.
Document Types: Article
Countries: Spain
Abstract: http://www3.interscience.wiley.com/journal/117983521/abstract?CRETRY=1&SRETRY=0
Condition Year Language Analysis type
Health economics, Oncology 2006 English
 
 
Copyright 2017 IMS Health Incorporated. All rights reserved.